Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatment. [electronic resource]
Producer: 20080306Description: 841-9 p. digitalISSN:- 1526-8209
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials as Topic
- Disease-Free Survival
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Neoplasm Metastasis
- Receptor, ErbB-2 -- drug effects
- Trastuzumab
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.